Nerve News and Research

RSS

Research reveals why a common genetic variant worsens outcomes for people with ALS and FTD

A pioneering new study led by UCL and National Institutes of Health (NIH) scientists has revealed, for the first time, why a common genetic variant worsens disease outcomes for people with the devastating adult-onset neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

24 Feb 2022

Scientists discover how a rare genetic disorder disrupts key neural interactions in the developing brain

Every time you chew, talk, yawn, or sense the zap of a toothache, cranial nerve cells are shuttling electrochemical signals to your brain.

23 Feb 2022

Researchers show how the biological system can be steered with artificial organic neurons

For the first time, researchers demonstrate an artificial organic neuron, a nerve cell, that can be integrated with a living plant and an artificial organic synapse.

23 Feb 2022

Neural mechanisms of fatigue in COVID-19 convalescents

In a recent study posted to the medRxiv* preprint server, researchers characterized the mechanisms associated with neural dysregulation in post-coronavirus disease (COVID) fatigue (pCF) by evaluating individuals recovered from mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

23 Feb 2022

‘Injections, injections, injections’: Troubling questions follow closure of sprawling pain clinic chain

On May 13 of last year, the cellphones of thousands of California residents undergoing treatment for chronic pain lit up with a terse text message: "Due to unforeseen circumstances, Lags Medical Centers will be closing effective May 19, 2021."

22 Feb 2022

Search for a treatment to stop nerve cell degeneration yields promising results

Researchers at the University of Illinois Chicago found promising results in their search for a treatment to stop nerve cell degeneration that happens in some types of disorders, such as hereditary spastic paraplegia and Parkinson's disease, which can cause significant disability.

17 Feb 2022

Twin study identifies the influence of environment and genetics in multiple sclerosis

Researchers at the University of Zurich and Munich's LMU Klinikum hospital have studied the immune system of pairs of monozygotic twins to identify the influence of the environment and of genetics in cases of multiple sclerosis.

16 Feb 2022

YME1L protein regulates the production of new nerve cells in the brain

Researchers at the University of Cologne have discovered that the protein YME1L regulates the production of new nerve cells and the maintenance of neural stem cells in the adult brain.

16 Feb 2022

Study identifies neurons that fire specifically during mathematical operations

The brain has neurons that fire specifically during certain mathematical operations. This is shown by a recent study conducted by the Universities of Tübingen and Bonn.

14 Feb 2022

Study points to vagus nerve dysfunction as a central pathophysiological feature of long COVID

New research to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2022, Lisbon, 23-26 April) suggests that many of the symptoms connected to post-COVID syndrome (PCC, also known as long COVID) could be linked to the effect of the virus on the vagus nerve – one of the most important multi-functional nerves in the body.

12 Feb 2022

Self-learning software detects peripheral arterial disease from high-resolution color fundus photography

Researchers at the University and the University Hospital of Bonn have developed a method that could be used to diagnose atherosclerosis.

12 Feb 2022

Alkem signs license agreement with Harvard to develop, commercialize new technology for treating ischemic conditions

Alkem Laboratories Limited, an Indian multinational pharmaceutical company, has signed a license agreement with Harvard University's Office of Technology Development enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD), and other injuries caused by vascular disease.

11 Feb 2022

Scientists discover a new class of potential drug targets for neurodegenerative diseases

Oregon State University scientists have discovered a new class of potential drug targets for people suffering from neurodegenerative conditions such as Alzheimer's, Parkinson's and Lou Gehrig's disease.

10 Feb 2022

Simple eye test may help identify Alzheimer’s risk in middle age

A simple eye test may make diagnosing the earliest stages of 'diseases of old age' possible when people are much younger, University of Otago researchers hope.

10 Feb 2022

Huntsman Mental Health Institute joins a national collaborative effort to tackle mood disorders

Huntsman Mental Health Institute at the University of Utah was designated a Center of Excellence and member of the National Network of Depression Centers (NNDC), a consortium of leading academic medical centers working to accelerate research, education, and improved treatment options for people with depressive and bipolar illnesses.

8 Feb 2022

Researchers develop new potential method for treating Alzheimer's disease

Researchers at the faculty have developed an artificial intelligence (AI) method to help them identify potential new medicines for Alzheimer's. The new medicine seems to be more precise. No side effects were documented during tests with worms and mice.

4 Feb 2022

Developing injectable granular hydrogels for brain regeneration and function recovery after stroke

The Centers for Disease Control and Prevention estimate that someone in the United States has a stroke every 40 seconds.

4 Feb 2022

New cloud-based data resource helps researchers to identify subtypes of ALS

A new cloud-based data resource co-developed by scientists at Cedars-Sinai provides the research community with a comprehensive set of tools to help identify new subtypes of amyotrophic lateral sclerosis (ALS), a fatal neurological disorder.

4 Feb 2022

Brains of adults with heart-healthy lifestyle are larger and show fewer signs of injury, research finds

On imaging tests, brains were larger and showed fewer signs of injury in early to late middle-aged adults (ages 40-69 years) who had nearly ideal cardiovascular health, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2022, a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health to be held in person in New Orleans and virtually, Feb. 8-11, 2022.

3 Feb 2022

Study reveals a direct correlation between fat browning and consumption of flavan 3-ols

In cold conditions, brown adipose tissue (BAT) or brown fat generates heat to keep the body warm. Compared with white adipose tissue, BAT has more mitochondria - subcellular organelles associated with energy production - which allows it to burn calories and produce heat by activating the mitochondrial uncoupling protein 1 (Ucp-1).

2 Feb 2022

Nerve News and Research

Research reveals why a common genetic variant worsens outcomes for people with ALS and FTD

Scientists discover how a rare genetic disorder disrupts key neural interactions in the developing brain

Researchers show how the biological system can be steered with artificial organic neurons

Neural mechanisms of fatigue in COVID-19 convalescents

‘Injections, injections, injections’: Troubling questions follow closure of sprawling pain clinic chain

Search for a treatment to stop nerve cell degeneration yields promising results

Twin study identifies the influence of environment and genetics in multiple sclerosis

YME1L protein regulates the production of new nerve cells in the brain

Study identifies neurons that fire specifically during mathematical operations

Study points to vagus nerve dysfunction as a central pathophysiological feature of long COVID

Self-learning software detects peripheral arterial disease from high-resolution color fundus photography

Alkem signs license agreement with Harvard to develop, commercialize new technology for treating ischemic conditions

Scientists discover a new class of potential drug targets for neurodegenerative diseases

Simple eye test may help identify Alzheimer’s risk in middle age

Huntsman Mental Health Institute joins a national collaborative effort to tackle mood disorders

Researchers develop new potential method for treating Alzheimer's disease

Developing injectable granular hydrogels for brain regeneration and function recovery after stroke

New cloud-based data resource helps researchers to identify subtypes of ALS

Brains of adults with heart-healthy lifestyle are larger and show fewer signs of injury, research finds

Study reveals a direct correlation between fat browning and consumption of flavan 3-ols

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News